|
|
5/26/2005 9:20:59 AM ET
PMS ESCAPE® PRODUCT LAUNCHED WITH LARGE U.S. NATIONAL PHARMACY CHAIN PURCHASE ORDER
FOR IMMEDIATE RELEASE
Stock Symbol: OTC BB: SWME
May 26, 2005
PMS ESCAPE® PRODUCT LAUNCHED WITH LARGE U.S. NATIONAL PHARMACY CHAIN PURCHASE ORDER
Toronto, Canada – Swiss Medica, Inc. (OTC BB: SWME), is pleased to announce that it has received a purchase
order from a large U.S. national pharmacy chain for its U.S.-patented, clinically tested PMS Escape® product.
PMS Escape® will be available throughout the USA early this summer in that pharmacy chain. PMS Escape® is
the first product to achieve national pharmacy shelf space that was part of the acquisition of Anti-Depression
BioHealth Solutions, which was announced in a series of news releases dated April 5, 6, 12 and 13.
“We are excited to launch PMS Escape® in our first U.S. national pharmacy,” said Wendy Kramer, Swiss Medica’
s Vice President. “Commencing with a national footprint provides PMS Escape® with a strong presence in many
of the country’s largest markets. We believe this will offer millions of women the opportunity to purchase PMS
Escape® – a clinically studied, patented, safe and effective product for the normal mood and appetite symptoms
associated with premenstrual syndrome.”
Specific national pharmacy distribution details will be announced to coincide with the national U.S. advertising
launch after the PMS Escape® product is widely available on store shelves.
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our
market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a
world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please
visit our websites at www.swissmedica.com, www.O24zone.com and www.pmsescape.com.
Swiss Medica's flagship product, the O24™ Pain Neutralizer, holds US Patent #6,444,238B1. The O24™ pain
relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by
healthcare professionals in the United States, Canada and in Europe. O24™ is widely available throughout
Canada in leading pharmacies and natural food stores. It is currently sold in an increasing number of
pharmacies throughout the United States. Customers can also visit www.O24zone.com, for ordering details and
store locators for the nearest pharmacy.
Swiss Medica also manufactures PMS Escape® which holds US Patent #’s 5760014 and 5612320. PMS
Escape® is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce
changes in mood and appetite that women experience during the premenstrual period. Customers can also visit
www.pmsescape.com for additional information and ordering details.
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United
States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking
statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close
transactions being contemplated, risks related to international sales and potential foreign currency exchange
fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological
changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's
periodic reports filed with the United States Securities and Exchange Commission and other regulatory
authorities.
For more information, please contact:
Swiss Medica Inc.
Investor Relations Contact:
David Jones
(866) 485-4243
djones@swissmedica.com
|
|
